Key facts

Founded
2011
HQ
London, United Kingdom
Employees
—
Website
Funding stage
Private · venture-backed
Further facts
  • Investment: Silicon Valley-based Sumeru Partners invested US$70m in iProov.
  • Patents: The company has 27 granted patents and almost 200 employees.
  • Agents: In October 2026 iProov launched a human approval service for AI agent gateways, integrated with agentgateway and Cerbos.

Focus areas

Biometrics Liveness detection Identity verification Deepfake detection Authentication Agent governance

About

iProov is a London biometric identity company founded in 2011 by Andrew Bud, who remains chief executive. It is privately owned, has traded since 2013 and has 27 granted patents and almost 200 employees. Its face verification is used by banks including UBS, ING and Rabobank and by government digital identity programmes such as UK NHS login and schemes in Singapore and Australia. Sumeru Partners invested US$70m in the company.

How they use AI

iProov uses patented real-time liveness detection, Flashmark, to confirm that a face belongs to a real person present at the moment of verification and not a deepfake or replay. In October 2026 it launched a hosted Human Authorization and Presence Specification service that gives AI agents a signed proof that a named person approved a specific high-risk action.

Products and services

  • Dynamic Liveness — Flashmark-based liveness for high-assurance onboarding
  • Express Liveness — Lower-friction liveness for routine authentication
  • iSOC — Security operations centre that monitors threats across deployments
  • Human Authorization Service — Verified human approval for AI agent actions

Notable customers / partners

Key people

  • Andrew Bud — Founder and CEO

Investors

  • Sumeru Partners